BridgeMD
New treatment option for Image, Body
Official title Investigational MRI Clinical Software and Hardware
ClinicalTrials.gov ID: NCT05215132
What this study is testing
What is Gadavist 2Ml Solution for Injection?
Gadavist 2Ml Solution for Injection is an investigational medicine, being studied as a potential treatment for image, body.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Patients and healthy volunteers will be scanned in order to test new sequences.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90. Healthy volunteers may be eligible.
You may be able to join if
- At least 18 years of age
- Able to complete the MR safety questionnaire.
- Able to comprehend and provide informed consent in English.
- When contrast is being administered: healthy volunteers with a GFR≥60 ml/min
- When contrast is being administered: patients with a GFR ≥30 ml/min
You likely can't join if
- When contrast is being administered: people with a GFR \< 30 ml/min
- When contrast is being administered: people with acute kidney injury
- When contrast is administered, allergy to gadolinium-containing contrast media
- Contraindication to MRI (implanted device, claustrophobia, dyspnea precluding the ability to follow breath-hold instructions)
- Adults unable to consent
- Individuals who are not yet adults
See the full eligibility criteria
- At least 18 years of age
- Able to complete the MR safety questionnaire.
- Able to comprehend and provide informed consent in English.
- When contrast is being administered: healthy volunteers with a GFR≥60 ml/min
- When contrast is being administered: patients with a GFR ≥30 ml/min
- When contrast is being administered: people with a GFR \< 30 ml/min
- When contrast is being administered: people with acute kidney injury
- When contrast is administered, allergy to gadolinium-containing contrast media
- Contraindication to MRI (implanted device, claustrophobia, dyspnea precluding the ability to follow breath-hold instructions)
- Adults unable to consent
- Individuals who are not yet adults
- Pregnant or breastfeeding women
- Prisoners
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.